New medication shows promise as lipid-lowering therapy for rare cholesterol disorder
Friday, November 2, 2012 - 15:01
in Health & Medicine
An international effort has resulted in positive phase 3 clinical trial results for a new medicine to treat patients suffering from a rare and deadly cholesterol disorder, homozygous familial hypercholesterolemia.